URUrology Research3083-49102981-8230Bio-Byword Scientific Publishing Pty. Ltd.10.26689/ur.v1i3.6043ArticleA Case Report of Metastatic Melanoma to the Bladderhttps://artdesignp.com/journal/UR/1/3/10.26689/ur.v1i3.6043Ortiz-ZablehAna María,Sandoval-OjedaJuan Manuel,Patiño-CovelliNatalia,Bolívar-AguileraIsabel Cristina,Ortiz-AzueroAlfredo2023132023-12-31Objective: The objective of this report is to present the case of metastatic melanoma to the bladder, a rare and underdiagnosed condition due to its often asymptomatic characteristic. Case presentation: The case was a 62-year-old female patient, with a history of melanoma at the level of the first toe, with surgical and pharmacological management. The reason for consultation was hematuria. Cystoscopy revealed a single solid, erythematous lesion with necrosis and easy bleeding, and transurethral resection (TUR) was indicated. The pathology found metastatic ulcerated melanoma. Second-line treatment (pembrolizumab) was started and presented progression to the upper limbs and relapse at the bladder level. The patient died a year later. Discussion: Melanoma metastases to the genitourinary tract are common, but isolated bladder metastases are rare. Treatment is usually TUR of the lesion, cystectomy, chemotherapy, and radiation therapy. TUR is curative for lesions restricted to the epithelium, although radical cystectomy is usually the therapy of choice in patients with a localized tumor. Pembrolizumab has been shown to increase survival. The prognosis depends on the size and depth of the invasion. Conclusion: Metastatic cancer to the bladder is rare and underdiagnosed, it may be present in patients with melanoma, nonspecific urinary irritative symptoms, and hematuria. It tends to have a poor prognosis, and requires surgical treatment associated with systemic management.

Nualyong C, Woranisarakul V, Tantranont N, et al., 2018, Metastatic Malignant Melanoma of the Urinary Bladder: A Case Report and Review of the Literature. Siriraj Med J, 70(3): 254–259. https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/129734

Bates AW, Baithun SI, 2000, Secondary Neoplasms of the Bladder are Histological Mimics of Nontransitional Cell Primary Tumours: Clinicopathological and Histological Features of 282 Cases. Histopathology, 36(1): 32–40. https://doi.org/10.1046/j.1365-2559.2000.00797.x

Ganem E, Batal J, 1956, Secondary Malignant Tumors of the Urinary Bladder Metastatic from Primary Foci in Distant Organs. J Urol, 75(6): 965–972. https://doi.org/10.1016/s0022-5347(17)66911-8

Dasgupta T, Brasfield R, 1964, Metastatic Melanoma: A Clinicopathological Study. Cancer, 17(10): 1323–1339.

Klinger ME, 1951, Secondary Tumors of the Genito-Urinary Tract. J Urol, 65(1): 144–153. https://doi.org/10.1016/s0022-5347(17)68470-2

Niederberger CS, Lome LG, 1993, Primary Malignant Melanoma of Urinary Bladder. Urology, 41(1): 72–74. https://doi.org/10.1016/0090-4295(93)90250-e

Efesoy O, Cayan S, 2011, Bladder Metastasis of Malignant Melanoma: A Case Report and Review of Literature. Med Oncol, 28(1): 667–669. https://doi.org/10.1007/s12032-010-9730-x

Añón-Requena MJ, Muñoz-Arias G, Ramírez-Chamorro R, 2015, Metastatic Malignant Melanoma of the Urinary Bladder. Actas Urol Esp, 39(10): 652–653. https://doi.org/10.1016/j.acuro.2015.05.009

Demirkesen O, Yaycioglu O, Uygun N, et al., 2000, A Case of Metastatic Malignant Melanoma Presenting with Hematuria. Urol Int, 64(2): 118–120. https://doi.org/10.1159/000030506

Casimiro-Guzmán L, Hernández-Román LU, Cruz-Contreras LH, et al., 2015, Bladder Melanoma, Case Report and Literature Review. Rev Mex de Urol, 75(5): 306–309.

Moore NA, Stunell HJ, Sizer B, et al., 2015, Malignant Melanoma Metastasis to the Urinary Bladder: A Rare Cystoscopic Finding. J Clin Urol, 8(2): 143–146. https://doi.org/10.1177%2F2051415813510712

Wisenbaugh ES, Stanton ML, Grimsby GM, et al., 2012, Metastatic Malignant Melanoma to the Bladder: A Case Series. Current Urology, 6(1): 53–56. https://doi.org/10.1159/000338872

Meunier R, Pareek G, Amin A, 2015, Metastasis of Malignant Melanoma to Urinary Bladder: A Case Report and Review of the Literature. Case Rep Pathol, 2015(2015): 1–6. https://dx.doi.org/10.1155%2F2015%2F173870

Venyo AK-G, 2014, Melanoma of the Urinary Bladder: A Review of the Literature. Surg Res Pract, 2014(2014): 1–13. https://dx.doi.org/10.1155%2F2014%2F605802

Khan M, O’Kane D, Plessis JD, et al., 2016, Primary Malignant Melanoma of the Urinary Bladder and Ureter. Can J Urol, 23(1): 8171–8175. https://pubmed.ncbi.nlm.nih.gov/26892061/

Lamichhane N, Dhakal HP, 2016, Melanoma of Urinary Bladder Presented as Acute Urine Retention. J Urol Res, 3(3): 1054. https://www.researchgate.net/publication/303451018_Melanoma_of_Urinary_Bladder_Presented_as_Acute_Urine_Retention

Specenier P, 2017, Pembrolizumab Use for the Treatment of Advanced Melanoma. Expert Opin Biol Ther, 17(6): 765–880. https://doi.org/10.1080/14712598.2017.1309388

Deeks ED, 2016, Pembrolizumab: A Review in Advanced Melanoma. Drugs, 2016(76): 375–386. https://doi.org/10.1007/s40265-016-0543-x

Lee CSD, Komenaka IK, Hurst-Wicker KS, et al., 2003, Management of Metastatic Malignant Melanoma of the Bladder. Urology, 62(2): 351. https://doi.org/10.1016/s0090-4295(03)00354-6

Crosby T, Fish R, Coles B, et al., 2018, Systemic Treatments for Metastatic Cutaneous Melanoma. Cochrane Database Syst Rev, 2(2). https://dx.doi.org/10.1002%2F14651858.CD001215.pub2